Wave Life Sciences Ltd (WVE NASDAQ) stock market data APIs
$5.0802
0.29(5.7%)
as of August 17, 2026
Try our APIs with
free plan!
Wave Life Sciences Ltd Financial Data Overview
Price chart is built with
Anychart
Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Prev. Close
5.0802
Open
5.3707
High
5.423
Low
5.0631
52 wk Range
5.01-21.73
Market Cap
1 003 M
Shares Outstanding
197 M
Revenue
65 371 K
EPS
-0.34
Beta
-1.287
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Wave Life Sciences Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Wave Life Sciences Ltd data using free add-ons & libraries
Get Wave Life Sciences Ltd Fundamental Data
Wave Life Sciences Ltd Fundamental data includes:
- Net Revenue: 65 371 K
- EBITDA: -214 520 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-30
- EPS/Forecast: -0.31
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Wave Life Sciences Ltd News
New
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transfo...
SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat?
Shares of Sarepta Therapeutics SRPT fell nearly 10% over the past week. This decline likely reflects growing investor concerns about the company's position in the Duchenne muscular dystrophy (DMD) lan...
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
An updated edition of the June 2, 2026, article. Genomics is a broad and detailed study of genomes (an organism's complete set of deoxyribonucleic acid or DNA). Recent scientific advances in this are...
Is QURE Stock Attractive After Its Rally, Rich Valuation, and Hold?
uniQure N.V. QURE has surged as investors reassessed AMT-130, its lead gene therapy candidate for Huntington's disease. The question is whether the move already reflects too much optimism. Valuation,...
Get Wave Life Sciences Ltd fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
